BioSpace News Archive

MCRA, LLC has announced its role in the successful granting of the first De Novo for a device intended to be used in the spine by the U.S. Food and Drug Administration on March 28, 2019.

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in personalized medicine,today announced that it has expanded its companion diagnostic collaboration with AstraZeneca and Merck (known as MSD outside the US and Canada).

The National Basketball Athletic Trainers’ Association welcomes KT Tape, the leading producer of kinesiology tape and related sports performance products in the retail market, to the NBATA partnership family as the “Official Kinesiology Tape Sponsor of NBATA”.

Ditch the Razor with Ideal Image at the Spring into Summer Skin & Body Event

Santhera Pharmaceuticals (SIX: SANN) announces that it has placed all of the remaining 500,000 registered shares from its existing authorized share capital in a private placement, resulting in aggregate gross proceeds of CHF 7.1 million.

Cook Biotech announced a new sales collaboration with Progressive Medical.

The U.S. Food and Drug Administration and the U.S. Customs and Border Protection leaders signed an agreement to maximize inspection and detection capabilities in order to prevent illegal and harmful products entering the U.S. through the nation’s International Mail Facilities and Ports of Entry that pose a threat to public health.

New safes for controlled substances will help combat opioid epidemic in the state and reduce robbery incidents

Approval of expanded indication based predominately on real-world data

April is Cancer Control Month and Combined Insurance is dedicated to raising awareness for the early detection and treatment of cancer.